Is one trial enough for repeated testing? Same-day assessments of walking, mobility and fine hand use in people with myotonic dystrophy type 1

详细信息    查看全文

• 作者：Marie Kierkegaard^a ; ^b ; ^c ; ^{marie.kierkegaard@ki.se} ; ^{marie.kierkegaard@karolinska.se} ; Emilie Petitclerc^b ; ^c ; Luc J. Hé ; bert^d ; ^e ; Cynthia Gagnon^b ; ^c
• 关键词：Myotonic dystrophy ; Outcome measures ; Reliability ; Number of trials ; Repeated measures ; Rehabilitation
• 刊名：Neuromuscular Disorders
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：27
• 期：2
• 页码：153-158
• 全文大小：420 K
• 卷排序：27

文摘

Physical function assessments are essential in myotonic dystrophy type 1 (DM1). Performance-based measures of walking, mobility and fine hand use are commonly used. Number of trials needed at a same-day test occasion was explored in 70 adults with DM1. Depending on test, one or two trials seem sufficient for a same-day assessment. People with severe muscular impairments had difficulties to perform repeated trials.